| 1 |
Liu Z, Suo C, Mao X, et al. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017[J]. Cancer, 2020, 126(10)：2267-2278.
|
| 2 |
Chang A, Ganz P, Hayes D, el al. Oncology: an evidence-based approach[M]. New York: Springer, 2006：449-486.
|
| 3 |
Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer[J]. Ann Oncol, 2016, 27(8)：1386-1422.
|
| 4 |
Shindoh J. Risk stratification and goal of systemic therapy for successful surgical management of colorectal liver metastases: Oncological optimization[J]. J Hepatobiliary Pancreat Sci, 2021, 28(6)：461-469.
|
| 5 |
Yamamoto M, Yoshida M, Furuse J, et al. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021[J]. J Hepatobiliary Pancreat Sci, 2021, 28(1)：1-25.
|
| 6 |
王鲁. 转移性肝癌的外科治疗[J]. 肝胆外科杂志，2017, 25(4)：305-307.
|
| 7 |
中华医学会外科分会胃肠外科学组，中华医学会外科分会结直肠外科学组，中国抗癌协会大肠癌专业委员会，等. 中国结直肠癌肝转移诊断和综合治疗指南(V 2018)[J/CD]. 中华结直肠疾病电子杂志，2018(4)：302-314.
|
| 8 |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)结直肠癌诊疗指南[M]. 北京：人民卫生出版社，2022：64-67.
|
| 9 |
National Comprehensive Cancer Network. Recent updates to NCCN clinical practice guidelines in oncology-colon cancer(version 4.2020) and rectal cancer (version 1.2020) [DB/OL].
URL
|
| 10 |
中华医学会外科学分会胰腺外科学组. 胰腺神经内分泌肿瘤治疗指南(2014)[J]. 中华肝胆外科杂志，2014，20(12)：841-844.
|
| 11 |
Partelli S, Bartsch DK, Capdevila J, et al, ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours[J]. Neuroendocrinology, 2017, 105(3)：255-265.
|
| 12 |
Pavel M, Öberg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2020, 31(7)：844-860.
|
| 13 |
Kurihara T, Itoh S, Kimura Y, et al. Feasibility of hepatic resection for liver metastasis of head-and-neck carcinoma or esophageal carcinoma: a multi-center experience[J]. Surg Today, 2021, 51(12)：1932-1937.
|
| 14 |
Pawlik TM, Gleisner AL, Bauer TW, et al. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis[J]. Ann Surg Oncol, 2007, 14(10)：2807-2816.
|
| 15 |
Ai D, Zhu H, Ren W, et al. Patterns of distant organ metastases in esophageal cancer: a population-based study[J]. J Thorac Dis, 2017, 9(9)：3023-3030.
|
| 16 |
Zhang S, Guo J, Zhang H, et al. Metastasis pattern and prognosis in men with esophageal cancer patients: a SEER-based study. Medicine (Baltimore)[J]. 2021, 100(25)：e26496.
|
| 17 |
Li H, Zhang S, Guo J, et al. Hepatic metastasis in newly diagnosed esophageal cancer: a population-based study[J]. Front Oncol, 2021, 11：644860.
|
| 18 |
Adam R, Chiche L, Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1，452 patients and development of a prognostic model[J]. Ann Surg, 2006, 244(4)：524-535.
|
| 19 |
Ichida H, Imamura H, Yoshimoto J, et al. Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma[J]. World J Surg, 2013, 37(2)：398-407.
|
| 20 |
Liu J, Wei Z, Wang Y, et al. Hepatic resection for post-operative solitary liver metastasis from oesophageal squamous cell carcinoma[J]. ANZ J Surg, 2018, 88(4)：E252-E256.
|
| 21 |
Urabe M, Yagi K, Shiomi S, et al. Implications of liver-directed therapy for postoperative hepatic metastasis from esophageal cancer[J]. J Chest Surg, 2022, 55(5)：397-404.
|
| 22 |
曹亚娟，黎兵华，余德才. 转化治疗联合Laennec入路机器人右半肝切除治疗进展期肝癌[J/CD]. 中华腔镜外科杂志(电子版), 2023, 16(2): 116-119.
|